CPR offers new PR therapy for anti-cancer treatments

Pharmaceutical giant Bristol-Myers Squibb has handed Complete Pharma PR the pan-European business for its portfolio of anti-cancer products.

Pharmaceutical giant Bristol-Myers Squibb has handed Complete

Pharma PR the pan-European business for its portfolio of anti-cancer

products.



CPR won the six-figure account following a competitive two-way pitch

against Edelman London. The brief is to provide strategic communications

recommendations and creative concepts for Bristol-Myers Squibb’s full

portfolio of current and pipeline oncology products, which include

TAXOL, Paraplatin, Platinol and VePesid.



’A key task will be maintaining Bristol-Myers Squibb’s voice and

presence at key meetings throughout the world,’ said CPR managing

director Scott Clark.



CPR will target a wide-ranging audience, including healthcare

professionals, patients and their families.



The oncology account was previously handled by Burson-Marsteller, but

the agency and Bristol-Myers Squibb ended their contract by mutual

agreement at the beginning of the year. Shire Hall took over the account

for the Caring About Women Against Cancer campaign from B-M. The

campaign, which is launching at the beginning of 1998, covers 17

European countries. Shire Hall has also handled the account for TAXOL

for the last three and a half years for Bristol-Myers Squibb UK.



B-M continue to hold the accounts for Bristol-Myers Squibb’s

cardiovascular and cholestrol lowering products.



Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

Would you like to post a comment?

Please Sign in or register.